Liver involvement in cardiovascular patients: role of perilipin-2 as a liver-specific biomarker, beyond cardiac damage

17 May 2025 (12:12 - 13:48)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Isabella Fumarulo

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail

Non-cell autonomous effects of Dnmt3a-mutant clonal haematopoiesis in ST-elevation myocardial infarction

Doctor M. Sadler (London, GB)

Abstract Slides Video

Presentation thumbnail

The role of left ventricular global longitudinal strain and myeloperoxidase in prognostication of major adverse clinical events for patients with ST elevation myocardial infarction and obesity

Doctor A. Kobets (Kharkiv, UA)

Abstract Slides Video

Presentation thumbnail

The effect of S-glutathionylation on passive stiffness decreases with the maturation of sarcomeric structure

Miss B. Bodi (Debrecen, HU)

Abstract Slides Video

Presentation thumbnail

Sacubitril/Valsartan enhances skin wound healing through a sustained anti-inflammatory action; Implications for cardiac wound healing and cardiac reverse remodelling

Doctor A. Ntalianis (Athens, GR)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in basic science (1)

The Event

Event poster

Heart Failure 2025

17 May 2025 12:12 CET

You may be interested in

Congress Presentation

Novel LiverRisk score is associated with adverse outcome in heart failure: insights from the BIOSTAT-CHF study

Congress Presentation

Incremental prognostic value of metabolic dysfunction-associated fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease

Congress Presentation

Fatty liver disease as risk factors for the clinical expression of hypertrophic cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources